389 related articles for article (PubMed ID: 33983973)
1. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
Peterson J; Gisslen M; Zetterberg H; Fuchs D; Shacklett BL; Hagberg L; Yiannoutsos CT; Spudich SS; Price RW
PLoS One; 2014; 9(12):e116081. PubMed ID: 25541953
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.
Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew B; Fuchs D; Tambussi G; Cinque P; Hecht FM; Price RW
J Infect Dis; 2011 Sep; 204(5):753-60. PubMed ID: 21844301
[TBL] [Abstract][Full Text] [Related]
4. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
[TBL] [Abstract][Full Text] [Related]
5. Cerebral white matter integrity during primary HIV infection.
Wright PW; Vaida FF; Fernández-de Thomas RJ; Rutlin J; Price RW; Lee E; Peterson J; Fuchs D; Shimony JS; Robertson KR; Walter R; Meyerhoff DJ; Spudich S; Ances BM
AIDS; 2015 Feb; 29(4):433-42. PubMed ID: 25513818
[TBL] [Abstract][Full Text] [Related]
6. Dynamic of CSF and serum biomarkers in HIV-1 subtype C encephalitis with CNS genetic compartmentalization-case study.
de Almeida SM; Rotta I; Ribeiro CE; Oliveira MF; Chaillon A; de Pereira AP; Cunha AP; Zonta M; Bents JF; Raboni SM; Smith D; Letendre S; Ellis RJ
J Neurovirol; 2017 Jun; 23(3):460-473. PubMed ID: 28247269
[TBL] [Abstract][Full Text] [Related]
7. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.
Suh J; Sinclair E; Peterson J; Lee E; Kyriakides TC; Li FY; Hagberg L; Fuchs D; Price RW; Gisslen M; Spudich S
J Neuroinflammation; 2014 Dec; 11():199. PubMed ID: 25465205
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
Sinclair E; Ronquillo R; Lollo N; Deeks SG; Hunt P; Yiannoutsos CT; Spudich S; Price RW
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):544-52. PubMed ID: 18362693
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
10. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
[TBL] [Abstract][Full Text] [Related]
11. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
12. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
[TBL] [Abstract][Full Text] [Related]
13. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
15. Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations.
Oliveira MF; Chaillon A; Nakazawa M; Vargas M; Letendre SL; Strain MC; Ellis RJ; Morris S; Little SJ; Smith DM; Gianella S
PLoS Pathog; 2017 Jan; 13(1):e1006112. PubMed ID: 28046096
[TBL] [Abstract][Full Text] [Related]
16. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers.
Dahl V; Peterson J; Spudich S; Lee E; Shacklett BL; Price RW; Palmer S
AIDS; 2013 Apr; 27(7):1145-9. PubMed ID: 23211774
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.
de Almeida SM; Rotta I; Jiang Y; Li X; Raboni SM; Ribeiro CE; Smith D; Potter M; Vaida F; Letendre S; Ellis RJ;
J Neurovirol; 2016 Dec; 22(6):715-724. PubMed ID: 27400932
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
19. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy.
Dahl V; Lee E; Peterson J; Spudich SS; Leppla I; Sinclair E; Fuchs D; Palmer S; Price RW
J Infect Dis; 2011 Dec; 204(12):1936-45. PubMed ID: 22021620
[TBL] [Abstract][Full Text] [Related]
20. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
Livelli A; Vaida F; Ellis RJ; Ma Q; Ferrara M; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Sacktor N; Simpson DM; Grant I; Letendre SL;
Lancet HIV; 2019 Jul; 6(7):e456-e462. PubMed ID: 31208949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]